IOVAIovance Biotherapeutics, Inc.
$14.08+529% 1Y
$14.08
$1.8152 weeks$14.87
Is the price fair?
What IOVA's price assumes
Iovance Biotherapeutics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 19.6× revenue.
19.6
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 8.67
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 18.7
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 8.67
- EV / EBIToperating margin −93%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 18.7
- Market capitalisation453.0 million shares, counted Jul 29, 2026
- $6.38B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks